A tuberculosis TB vaccine to prevent reactivation

Details for Australian Patent Application No. 2010238943 (hide)

Owner Statens Serum Institut

Inventors Dietrich, Jes; Andersen, Peter; Lundberg, Carina Vingsbo; Hoang, Truc Thi Kim Than

Agent Shelston IP

Pub. Number AU-A-2010238943

PCT Pub. Number WO2010/121618

Priority PA 2009 00539 24.04.09 DK

Filing date 23 April 2010

Wipo publication date 28 October 2010

International Classifications

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/121618 Priority application(s): WO2010/121618

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010238945-Particulate material for controlled release of active ingredients

2010238925-Particulate pharmaceutical composition having an opioid and an opioid antagonist